Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RFT5-dgA in Metastatic Melanoma
NCT00314093Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Apr 2006
- Primary completion
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes, Antibody-Drug Conjugates (ADCs), Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of RFT5-SMPT-dgA in melanoma, sponsored by UT Southwestern Medical Center. Started Apr 2006; status: completed.
02
Drugs
RFT5-SMPT-dgA
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00314093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314093.